Malaysia
Search
Sign In
Ophthalmology
Top Medical News
Treatment with repeated low-level red-light (RLRL) therapy with 100-percent power results in significant reduction in myopia progression over 6 months in myopic children when compared to a sham device with 10-percent original power, a China study has shown. In addition, the RLRL therapy is well tolerated and does not lead to serious adverse effects (AEs)
Consumption of alcoholic beverage in the long term may contribute to an increased risk of exfoliation glaucoma or glaucoma suspect (XFG/XFGS) status, suggests a US study.
Individuals with high blood pressure (BP), stage 1 hypertension, and stage 2 hypertension are at greater risk of retinal vascular occlusion relative to those with normal BP, as reported in a study.
The term ‘papilledema’ is often used inappropriately among case reports in ophthalmology, reveals a recent study. Such misuse, if not corrected, can result in improper care delivery to patients with optic disc edema (ODE), which may then lead to permanent vision loss.
Use of proprotein convertase subtilisin-like/kexin type 9 (PCSK9) inhibitors appears to increase the risk of ocular disorders, as shown in a study.
Smokers with thyroid eye disease are more likely to undergo surgery for their condition compared with their counterparts who do not smoke, a study has found.
A trio of engineers has developed a smart cane that provides navigation assistance with warning vibrations and spoken directions, enhancing the independence of people with blindness or visual impairments by helping them find a seat in a public space or the right products in a grocery store, among others.
Special Reports
Adalimumab soln for inj 40 mg/0.8 mL
A new algorithm objectively determines when intraocular lens implant (IOL) surgery should be performed, regardless of how the opacity looks to the surgeon.
Bilastine 10 mg orodispersible tablet
Roxadustat treatment for anaemia in patients with dialysis-dependent chronic kidney disease (DD CKD) does not come with an increased risk of ophthalmic abnormalities, according to a phase III trial conducted in Japan.
